Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
A chemical bond discovered by Vanderbilt University scientists that is essential for animal life and which hastened the "dawn of the animal kingdom" could lead to new therapies for cancer and other diseases.
The report, published online by the Proceedings of the National Academy of Sciences(PNAS), was co-authored by 83 participants in the "Aspirnaut" K-20 STEM pipeline program for diversity. Six were middle school students when the study was conducted, 42 were high school students, 30 were college undergraduates and five were graduate students.
Because many of the high school students grew up in poverty in rural communities, "they're invisible. They're an untapped talent pool," said Billy Hudson, Ph.D., who founded the Aspirnaut program with his wife and co-senior author Julie Hudson, M.D. "Aspirnaut connects the 'Forgotten Student' to STEM opportunities."
The study demonstrates that the sulfilimine bond, which Hudson's group discovered in 2009, is part of a "primordial innovation" dating back more than 500 million years to the ancestor of jellyfish. The bond stabilizes the collagen IV scaffold and is essential for more advanced tissue formation.
The bond is formed by hypohalous acids, a form of household bleach, generated by peroxidasin, an ancient enzyme embedded in the extracellular environment. This "oxidant generator" is key to forming new blood vessels that feed tumors, making it an attractive target for developing new drugs for cancer therapy, the researchers said.
The involvement of so many young students in a scientific publication is "rare, the first that I know of," said PNAS Editor-in-Chief Inder Verma, Ph.D. "It is a remarkable achievement," added Mina Bissell, Ph.D., who conducted the initial review of the manuscript for the journal.
During the summers of 2009 to 2013, the students participated in an "Expedition to the Dawn of the Animal Kingdom," a summer research program at Vanderbilt to search for the evolutionary origin of the sulfilimine chemical bond.
They contributed to experiments that showed the sulfilimine bond and the peroxidasin-based mechanism by which it forms can be traced to a common ancestor dating back more than 500 million years ago.
Of the 42 high-school researchers, 31 have now graduated. Thirty are attending or have completed college, 26 with STEM (science, technology, engineering and mathematics) majors.
The Aspirnaut program provides a summer research experience at Vanderbilt for students from underrepresented groups, many of whom are low-income.
The program was established in 2007 by Julie Hudson, M.D., assistant vice chancellor for Health Affairs at Vanderbilt, and her husband, internationally known scientist Billy Hudson, Ph.D., to elevate achievement in STEM. In 2009, the program received Recovery Act funding from the National Institutes of Health (DK065123).
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Cancer / Oncology category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Vanderbilt University Medical Center. "New therapies for cancer likely following discovery of ancient chemical bond." Medical News Today. MediLexicon, Intl., 20 Dec. 2013. Web.
9 Mar. 2014. <http://www.medicalnewstoday.com/releases/270279>
Vanderbilt University Medical Center. (2013, December 20). "New therapies for cancer likely following discovery of ancient chemical bond." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/270279.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.